| 000 | 01888 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517011345.0 | ||
| 264 | 0 | _c20151001 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0115869 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHagleitner, Melanie M | |
| 245 | 0 | 0 |
_aInfluence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. _h[electronic resource] |
| 260 |
_bPloS one _c2014 |
||
| 300 |
_ae115869 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCatechol O-Methyltransferase _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHearing Loss _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethyltransferases _xgenetics |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCoenen, Marieke J H | |
| 700 | 1 | _aPatino-Garcia, Ana | |
| 700 | 1 | _ade Bont, Eveline S J M | |
| 700 | 1 | _aGonzalez-Neira, Anna | |
| 700 | 1 | _aVos, Hanneke I | |
| 700 | 1 | _avan Leeuwen, Frank N | |
| 700 | 1 | _aGelderblom, Hans | |
| 700 | 1 | _aHoogerbrugge, Peter M | |
| 700 | 1 | _aGuchelaar, Henk-Jan | |
| 700 | 1 | _aTe Loo, Maroeska W M | |
| 773 | 0 |
_tPloS one _gvol. 9 _gno. 12 _gp. e115869 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0115869 _zAvailable from publisher's website |
| 999 |
_c24498770 _d24498770 |
||